Swiss venture capital vehicle HBM Bioventures said on Monday that it intends to proceed with an IPO, but make its offer conditional. Given the stock market’s recent rough ride, it will list on the Swiss exchange and sell new shares –– provided that investors pay the right price.
...
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: subs@globalcapital.com
Corporate access
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.
